NSE/JSLL

JSLLJSLL

NSE Equity · NSE

₹686.25+0.97%

52-wk low52-WEEK RANGE52-wk high

₹415.15+65.3% from low ·-70.8% from high₹2,353.9

Price chart · 1M–10Y · daily-close

NSE bhavcopy + 10Y historical

JSLL-68.09% · 1Y

Range high ₹2,450Range low ₹400.25Latest ₹686.25252 bars · daily-close · NSE bhavcopy + 10Y history

NSE EquityMedical Care FacilitiesSmallcapMedium Risk

Stock scorecard

Auto-computed from latest ratios + sector context · not a buy/sell signal

Composite50/100

Performance

Low

Hasn't fared well — amongst the weak performers.

· 52w return -70.3% — underperformer
· Below 200-DMA (-1.1%) — downtrend

Valuation

High

Looks expensive vs the sector.

DVM composite · Durability · Valuation · Momentum

Trendlyne-style 3-axis composite · all drivers shown below · not a buy/sell signal

CompositeC(56/100)

Durability

A+

100/100

Financially resilient — strong quality + solvency profile.

Show 2 drivers

Debt/Equity0.30 (100pt)
ROE60.0% (100pt)

Valuation

17/100

Richly valued on most axes; limited margin of safety.

Show 4 drivers

P/E vs sector (39.5 / 24.8)159% (28pt)
P/B23.74 (0pt)
Dividend yield0.16% (4pt)
EV/EBITDA29.4 (21pt)

Momentum

50/100

Momentum is muted; trend is unclear or rolling over.

Show 5 drivers

52w change-70.3% (0pt)
DMA-trend alignmentup (75pt)
RSI (14)63.1 (92pt)
Price vs 200-DMA+1.8% (50pt)
MACD regimebullish (75pt)

Valuation positioning

Current ratio vs sector peer distribution

P/E (TTM)39.54

FAIR

CheapestP/E 39.5 near sector median.Most expensive

P/B23.74

OVERVALUED

CheapestP/B 23.74 at 89th %ile of sector.Most expensive

EV/EBITDA29.38

OVERVALUED

Monthly seasonality

Avg monthly return over 4 years · historical — not a forecast

Best: Jul +29.78% · Worst: Jun -20.97%

Jan

+6.0%

50% win

Feb

-3.0%

25% win

Mar

+10.5%

50% win

Apr

+12.0%

75% win

May

+18.8%

100% win

Jun

-21.0%

Monthly return distribution

Distribution of 47 monthly returns

Mean

+8.71%

Median

+6.61%

Std dev

27.06%

Best

+102.0%

Worst

-80.0%

% positive

55%

SWOT analysis

Auto-derived from ratios + sector context + forensics · research only, not a recommendation

STRENGTHS · 2

High-quality compounder (ROE 60.0%)
Above 20% ROE consistently flags capital-efficient businesses
Top quartile ROE in Other
Rank 9 of 1000 peers

WEAKNESSES · 1

Premium to sector on P/E (+59%)
P/E 39.5 vs Other median 24.8

OPPORTUNITIES · 1

78% upside to consensus target (₹1200)
1 analysts see fair value materially higher

THREATS · 1

Valuation compression risk
P/E 39.5 is 59% above sector — any growth miss gets punished

RETURNS · DAILY-CLOSE BASED

3Y+ shown as CAGR

+1.0%

+2.9%

+17.9%

+0.0%

-15.5%

-66.5%

+63.7%

+64.7%

10Y

—

Peer	Last close	1Y change	Mcap ₹Cr	P/E	P/B	ROE	D/E	Rev YoY
JSLLTHIS Jeena Sikho Lifecare Limited	₹686.25	-70.3%	8,399	39.5	23.74	60.0%	0.30	+91.6%
ABCAPITAL Aditya Birla Capital Limited	₹340.4	+68.1%	89,888	25.8	2.79	10.8%	4.60	+17.6%
ABBOTINDIA Abbott India Limited	₹25,785	-16.6%	54,547	35.8	13.60	38.0%	0.04	+9.6%
360ONE 360 ONE WAM LIMITED	₹1,113.3	+16.7%	44,744	38.7	4.77	12.3%	1.47	+35.0%
3MINDIA 3M India Limited	₹31,410	+4.4%	35,158	92.9	21.83	23.5%	0.06	+6.1%
AADHARHFC Aadhar Housing Finance Limited	₹496.45	+3.5%	21,173	20.8	3.05	14.6%	2.55	—
ABDL Allied Blenders and Distillers Limited	₹573.8	+76.4%	16,176	60.4	10.70	17.7%	0.67	+5.8%
AAVAS Aavas Financiers Limited	₹1,347.9	-37.8%	10,612	17.1	2.26	13.3%	3.08	+13.3%
63MOONS 63 moons technologies limited	₹662.7	-9.8%	8,006	—	0.92	-0.2%	0.00	-6.3%

ASK AXEL

Dig deeper into JSLL

Axel can fetch latest news, peer valuation, consensus estimates, insider activity, and concall commentary for JSLL — all in one sourced reply.

Ask free in chat

Run these tools on JSLL

Historical return →

"If I had bought JSLL in year X"

Rolling returns →

Worst/best 1/3/5/7/10-yr windows

Buy-the-dip backtester →

Dip-buying vs SIP on JSLL

Brokerage + charges →

All-in cost for trading JSLL

Research tool · not investment advice.

Axel Markets is an information + analytics product. We are not a SEBI-registered Research Analyst (RA) or Investment Adviser (IA). Nothing on this page is a buy, sell, or hold recommendation. Past performance is not indicative of future returns. Verify all data against the authoritative source (NSE, BSE, AMFI, SEBI, company RHP / factsheet) before acting. Daily OHLCV sourced primarily from our NSE bhavcopy ingest (public sec_bhavdata_full CSV), with Stooq as a fallback for historical gaps. Split + bonus adjusted. Excludes dividends. Not a recommendation. Past performance does not predict future returns. For authoritative live quotes see NSE / BSE directly.

Date	Amount
2025-09-22	₹1.10
2024-08-20	₹0.84
2023-08-25	₹0.22

Date	Ratio
2025-06-12	5:1
2023-11-02	9:5

JSLLJSLL

Price chart · 1M–10Y · daily-close

Stock scorecard

DVM composite · Durability · Valuation · Momentum

Valuation positioning

Monthly seasonality

Monthly return distribution

SWOT analysis

Fundamentals

Pros and cons

Sector-relative context

Analyst consensus

Company + balance sheet snapshot

Peer comparison · Other

Ask Axel about JSLL

Recent news

Dig deeper into JSLL

Run these tools on JSLL

Technical snapshot

Dividends + splits history

Recent news

Fundamentals

Pros and cons

Sector-relative context

Analyst consensus

Company + balance sheet snapshot

Stock scorecard

SWOT analysis

DVM composite · Durability · Valuation · Momentum

Valuation positioning

Monthly seasonality

Monthly return distribution

Peer comparison · Other